BE Stock Recovers After 10% Selloff: Morgan Stanley Says Crusoe Project Pause Does Not Break AI Power Thesis
Bloom Energy (BE) stock recovered overnight after a nearly 10% selloff following the pause of a key data center project by Crusoe in Wyoming. Morgan Stanley maintained its "Overweight" rating and $310 price target, asserting that the project pause does not undermine their bullish thesis on Bloom Energy's role in AI power. RBC Capital also reiterated its "Outperform" rating and $335 price target, while retail sentiment on Stocktwits remained bearish despite a massive backlog.
Global Payments Stock Plummets 17% With 8-Day Losing Streak
Global Payments stock experienced a significant decline, plummeting 17% and extending its losing streak to eight days. The article title highlights the company's recent poor stock performance.
Morgan Stanley sharply revamps Cloudflare stock price target
Morgan Stanley has significantly increased its price target for Cloudflare (NET) to $305, maintaining an overweight rating, following Cloudflare's 2026 Investor Day. The revision is based on Cloudflare's ambitious new financial targets, including a "Rule of 50+" framework, raised operating margin goals, and a projection to reach a $5 billion revenue run-rate before the end of 2028. The firm highlighted a 1,700% surge in AI agent requests on Cloudflare's network, signaling a major platform shift in internet architecture.
Is MSA Safety (MSA) Quietly Redefining Its Moat With Connected Firefighter Gear Integration?
MSA Safety (MSA) recently launched new connected firefighter safety solutions, including expanded M1 SCBA telemetry, aiming to integrate data-rich systems into frontline gear. While this strategy reinforces MSA's focus on mission-critical protective equipment and could be crucial for future growth if demand stabilizes, investors should note that margin pressures from tariffs, inflation, and foreign exchange could still impact profitability. The company faces a projected revenue of $2.2 billion and earnings of $409.0 million by 2029, with fair value estimates ranging from US$205.71 to US$263.67 per share.
Kratos Turbojet Expansion Tests Valuation As Missile Demand Builds
Kratos Defense & Security Solutions (KTOS) is significantly expanding its Spartan turbojet engine production to 3,000 units next year, driven by increasing missile and loitering munition demand from U.S. and allied defense customers. While this positions KTOS as a key propulsion technology supplier, Simply Wall St's valuation model suggests the stock is currently trading above its fair value, despite analyst targets being significantly higher. Investors are advised to monitor contract mix, backlog, and capital spending as the production scales.
McGraw Hill, Inc. Stock 12‑Month Price Target Cut to $19.6, Implies 53% Upside
Analysts have cut the average 12-month price target for McGraw Hill, Inc. stock from $20.33 to $19.6, with individual forecasts ranging from $17 to $22 per share. This new target implies a potential 53% upside based on the closing price of June 10. Despite the target reduction, the consensus rating from 11 covering analysts remains "Buy," with 10 Buys and 1 Hold.
What Citigroup (C)'s US$3.15 Billion Note Redemption Means For Shareholders
Citigroup has redeemed US$3.15 billion in notes as part of its liability management program, aiming to streamline funding and capital structure. This action reinforces the bank's focus on balance sheet efficiency and cost discipline, supporting its "repair to growth" strategy. While this redemption is incremental, it aligns with management's efforts to improve returns, alongside other recent moves like hitting a 52-week high after strong earnings and significant stock repurchases.
Does Labcorp’s New Oncology Genetics Initiatives Shift the Precision Medicine Narrative For Labcorp (LH)?
Labcorp (LH) recently announced new oncology genetics initiatives, including a collaboration with the Alliance for Clinical Trials in Oncology for a colorectal cancer genetics trial and an expansion of its DPYD genotyping test. These moves strengthen Labcorp's position in precision medicine and oncology, leveraging its Invitae-based testing portfolio. While these advancements are significant for sharpening Labcorp's profile in a crucial growth area, they are not expected to immediately impact financial guidance but rather reinforce future growth catalysts in oncology and pharmacogenomics.
Schwab International Dividend Equity ETF (SCHY) stock price, news, quote and history
This article provides detailed financial information for the Schwab International Dividend Equity ETF (SCHY), including its current stock price, performance metrics, and a general overview. It highlights the ETF's objective to track high dividend-yielding stocks outside the United States and offers insights into its sector weightings and trailing returns. The page also features comparative data with similar ETFs and related tickers.
Liquidity Mapping Around (KJUN) Price Events
This article provides a liquidity mapping analysis for Innovator U.s. Small Cap Power Buffer Etf - June (KJUN), indicating a neutral sentiment across all time horizons. It outlines three AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, target, and stop-loss zones. The analysis also details near-term, mid-term, and long-term support and resistance signals for the ETF.







